mirage

Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Jódar Gimeno, Esteban
dc.contributor.author Doshi, A.
dc.contributor.author Gouet, D.
dc.contributor.author Oviedo, A.
dc.contributor.author Rodbard, H.W.
dc.contributor.author Tentolouris, N.
dc.contributor.author Busk, A.K.
dc.contributor.author Basse, A.
dc.contributor.author Billings, L.K.
dc.date.accessioned 2018-04-16T08:27:32Z
dc.date.available 2018-04-16T08:27:32Z
dc.date.issued 2017
dc.identifier.citation Jódar Gimeno, E., Doshi, A., Gouet, D., Oviedo, A., Rodbard, H.W., Tentolouris, N., Busk, A.K., Basse, A., & Billings, L.K. (2017). Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolustherapy in patients with type 2 diabetes: DUAL VII trial. Trabajo presentado en la 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). spa
dc.identifier.uri http://hdl.handle.net/11268/7224
dc.description.sponsorship Novo Nordisk A/S spa
dc.language.iso eng spa
dc.title Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial spa
dc.type conferenceObject spa
dc.description.impact No data (2017) spa
dc.rights.accessRights closedAccess spa
dc.subject.uem Diabetes tipo 2 spa
dc.subject.uem Insulina spa
dc.subject.unesco Sistema endocrino spa
dc.subject.unesco Tratamiento médico spa
dc.description.filiation UEM spa
dc.peerreviewed Si spa


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record